Comparison of two doses of cabazitaxel plus prednisone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen

MA Eisenberger; A-C Hardy-Bessard; L Mourey; PN Mainwaring; D Ford; JD Shapiro; J Carles; S Ng; T Gil; B Alekseev; S Ivanov; T Facchini; E Legouffe; O Apolikhin; HS Pandha; A Beeker; O Karyakin; W Zhang; M Chadjaa; JS De Bono

Back

Comparison of two doses of cabazitaxel plus prednisone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen

Conference presentation

Peer reviewed

Comparison of two doses of cabazitaxel plus prednisone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen

MA Eisenberger, A-C Hardy-Bessard, L Mourey, PN Mainwaring, D Ford, JD Shapiro, J Carles, S Ng, T Gil, B Alekseev, …

JOURNAL OF CLINICAL ONCOLOGY, Vol.30(15)

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) (Chicago, IL, 01/06/2012 - 06/06/2012)

20/05/2012

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802756&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

36 Record Views

Details

Title: Comparison of two doses of cabazitaxel plus prednisone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen
Creators: MA Eisenberger
A-C Hardy-Bessard
L Mourey
PN Mainwaring
D Ford
JD Shapiro
J Carles
S Ng
T Gil
B Alekseev
S Ivanov
T Facchini
E Legouffe
O Apolikhin
HS Pandha
A Beeker
O Karyakin
W Zhang
M Chadjaa
JS De Bono
Contributors: AMER SOC CLINICAL ONCOLOGY (Publisher)
Publication Details: JOURNAL OF CLINICAL ONCOLOGY, Vol.30(15)
Conference: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) (Chicago, IL, 01/06/2012 - 06/06/2012)
Date published: 20/05/2012
Date submitted: 17/05/2017
Identifiers: 99516633402346
Academic Unit: University of Surrey
Resource Type: Conference presentation

Comparison of two doses of cabazitaxel plus prednisone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel (D)-containing regimen

Abstract

Files and links (1)

Metrics

Details

Usage Policy